Works matching IS 02780232 AND DT 2024 AND VI 42 AND IP 5

Results: 14

Treatment‐free remission as a new goal in the management of chronic myeloid leukemia: Clinical and biological aspects.

Published in:

Hematological Oncology, 2024, v. 42, n. 5, p. 1, doi. 10.1002/hon.3309

By:

Cattaneo, Daniele;
Bucelli, Cristina;
Bellani, Valentina;
Mora, Barbara;
Iurlo, Alessandra

Publication type:

Article

Research on the mechanism of HOPX‐HDAC2 interaction inducing differentiation blockage in acute myeloid leukemia.

Published in:

Hematological Oncology, 2024, v. 42, n. 5, p. 1, doi. 10.1002/hon.3307

By:

He, Fang;
Tu, Yan;
Ni, Lihong

Publication type:

Article

Combined targeting of Hedgehog/GLI1 and Wnt/β‐catenin pathways in mantle cell lymphoma.

Published in:

Hematological Oncology, 2024, v. 42, n. 5, p. 1, doi. 10.1002/hon.3305

By:

Han, Yan;
Li, Chuntuan;
Liu, Shengquan;
Gao, Jingjing;
He, Yanjun;
Xiao, Huifang;
Chen, Qi;
Zheng, Yan;
Chen, Hongyuan;
Zhu, Xiongpeng

Publication type:

Article

Bruton tyrosine kinase inhibitor monotherapy in B‐cell lymphoma and risk of infection: A systematic review and meta‐analysis of randomized controlled trials.

Published in:

Hematological Oncology, 2024, v. 42, n. 5, p. 1, doi. 10.1002/hon.3308

By:

Zuber, Mohammed;
Borate, Samruddhi Nandkumar;
Gokhale, Pooja;
Yerubandi, Akhila;
Alam Bhuiya, N. M. Mahmudul;
Rawal, Smita;
Young, Henry N.;
Villa Zapata, Lorenzo

Publication type:

Article

Direct determination of chronic myeloid leukemia prevalence in Lombardy—Italy: Global implications.

Published in:

Hematological Oncology, 2024, v. 42, n. 5, p. 1, doi. 10.1002/hon.3311

By:

Polverelli, N.;
Anghilieri, M.;
Elena, C.;
Intermesoli, T.;
Pungolino, E.;
D'Adda, M.;
Iurlo, A.;
Maffioli, M.;
Lunghi, F.;
Bertolli, V.;
Orofino, N.;
Sissa, C.;
Fiamenghi, C.;
Gardellini, A.;
Ubezio, M.;
Carraro, M. C.;
Corradini, P.;
Giglio, F.;
Pasquini, M. C.;
Palazzolo, R.

Publication type:

Article

Secondary acute myeloid leukemia and early infection are independent predictors of poor survival in acute myeloid leukemia treated with hypomethylating agents and venetoclax.

Published in:

Hematological Oncology, 2024, v. 42, n. 5, p. 1, doi. 10.1002/hon.3310

By:

Cordella, Stefano;
Giusti, Davide;
De Bellis, Eleonora;
Dargenio, Michelina;
Creti', Federica;
Lazzarotto, Davide;
Cattaneo, Chiara;
Fracchiolla, Nicola Stefano;
Piccini, Matteo;
Forghieri, Fabio;
Pagano, Livio;
Candoni, Anna

Publication type:

Article

Adverse impact of 1q amplification on outcomes in patients with multiple myeloma treated with daratumumab, carfilzomib and dexamethasone in a real‐world clinical setting.

Published in:

Hematological Oncology, 2024, v. 42, n. 5, p. 1, doi. 10.1002/hon.3306

By:

Kikuchi, Taku;
Tsukada, Nobuhiro;
Kunisada, Kodai;
Matsumoto, Chiaki;
Nomura‐Yogo, Moe;
Oda, Yuki;
Sato, Kota;
Takei, Tomomi;
Ogura, Mizuki;
Abe, Yu;
Suzuki, Kenshi;
Hosoya, Osamu;
Ishida, Tadao

Publication type:

Article

From trials to statistical insights: Bortezomib's story in childhood T‐cell lymphoid malignancies.

Published in:

Hematological Oncology, 2024, v. 42, n. 5, p. 1, doi. 10.1002/hon.3304

By:

Srinivasan, Shyam

Publication type:

Article

Clinical characteristics and outcome of early‐stage diffuse large B cell lymphoma of female genital track: A retrospective study of the Hellenic cooperative lymphoma group.

Published in:

Hematological Oncology, 2024, v. 42, n. 5, p. 1, doi. 10.1002/hon.3303

By:

Verrou, Evgenia;
Papageorgiou, Sotirios G.;
Bouzani, Maria;
Sevastoudi, Aggeliki;
Triantafyllou, Theodora;
Daiou, Aikaterini;
Dalampira, Dimitra;
Arapaki, Maria;
Giatra, Chara;
Banti, Anastasia;
Kyriakidis, Gerasimos;
Stoumpos, Dionisios;
Karampatzakis, Nikolaos;
Papadopoulou, Theodosia;
Kotsopoulou, Maria;
Pouli, Anastasia;
Mandala, Evdokia;
Pappa, Vassiliki;
Spanoudakis, Emmanouil;
Katodritou, Eirini

Publication type:

Article

Prognostic value of the "dynamic" R2‐ISS in patients with multiple myeloma undergoing anti‐CD38 antibody‐based triplet therapies.

Published in:

Hematological Oncology, 2024, v. 42, n. 5, p. 1, doi. 10.1002/hon.3302

By:

Kikuchi, Taku;
Oda, Yuki;
Kondo, Ukyo;
Tsukada, Nobuhiro;
Kunisada, Kodai;
Matsumoto, Chiaki;
Nomura‐Yogo, Moe;
Sato, Kota;
Takei, Tomomi;
Ogura, Mizuki;
Abe, Yu;
Suzuki, Kenshi;
Hosoya, Osamu;
Ishida, Tadao

Publication type:

Article

Role of gut microbiome in the outcome of lymphoma patients treated with checkpoint inhibitors—The MicroLinf Study.

Published in:

Hematological Oncology, 2024, v. 42, n. 5, p. 1, doi. 10.1002/hon.3301

By:

Casadei, Beatrice;
Conti, Gabriele;
Barone, Monica;
Turroni, Silvia;
Guadagnuolo, Serafina;
Broccoli, Alessandro;
Brigidi, Patrizia;
Argnani, Lisa;
Zinzani, Pier Luigi

Publication type:

Article

Efficacy of escalating therapy with brentuximab vedotin‐AVD in advanced stage Hodgkin lymphoma patients with positive interim positron emission tomography after ABVD.

Published in:

Hematological Oncology, 2024, v. 42, n. 5, p. 1, doi. 10.1002/hon.3299

By:

Martínez, Carmen;
Carcelero, Esther;
Gutiérrez, Antonio;
Sancho, Esther;
Martí‐Tutusaus, Josep Maria;
Magnano, Laura;
Mozas, Pablo;
Fernández‐Avilés, Francesc;
Antelo, María Gabriela;
Setoain, Xavier;
Rodríguez, Sonia;
Esteve, Jordi

Publication type:

Article

Characteristics, outcomes and health care utilization of patients with acute myeloid leukemia aged 70 years or older: A single‐center retrospective analysis.

Published in:

Hematological Oncology, 2024, v. 42, n. 5, p. 1, doi. 10.1002/hon.3300

By:

Neumann, Marie Anne‐Catherine;
Naendrup, Jan‐Hendrik;
Garcia Borrega, Jorge;
Halmer, Ismini;
Altenrath, Lisa;
Sieg, Noelle;
Hallek, Michael;
Eichenauer, Dennis A.;
Heger, Jan‐Michel

Publication type:

Article

Issue Information.

Published in:: Hematological Oncology, 2024, v. 42, n. 5, p. 1, doi. 10.1002/hon.3181
Publication type:: Article